What happened

The trial for a lawsuit filed by Elon Musk against OpenAI CEO Sam Altman and President Greg Brockman began on April 27, 2026, creating a significant legal challenge to the corporate structure underpinning the company's IPO ambitions [2]. The lawsuit seeks more than $130 billion in damages and, most critically for potential public investors, the unwinding of OpenAI’s October 2025 conversion into a for-profit Public Benefit Corporation (PBC) [2], [5].

This restructuring was a foundational step toward a public listing, designed to allow the company to raise private and public capital while preserving its stated mission [4]. The conversion, which followed dialogue with the Attorneys General of California and Delaware, established OpenAI Group PBC as a for-profit entity controlled by the non-profit OpenAI Foundation [5]. Under this structure, the Foundation holds a 26% equity stake, with Microsoft holding approximately 27% and the remainder held by investors and employees [5]. The PBC framework was instrumental in enabling OpenAI to close a record-breaking $122 billion funding round on March 31, 2026, at an $852 billion valuation [2], [4].

How the market reacted

Prediction markets reflect high confidence in an eventual IPO despite the legal overhang. The Kalshi market contract for an official OpenAI IPO announcement by March 1, 2026 (KXIPOOPENAI), has consistently priced at its maximum value, indicating a consensus view of near-certainty based on months of public reporting and corporate actions [3].

However, a clean, time-aligned market reaction to the commencement of the Musk trial was not observable [3]. The market’s stability suggests that pricing reflects a cumulative assessment of OpenAI's preparatory steps—such as its massive funding round, key executive hires, and structural changes—rather than a response to individual news events like the trial, which represents a known, albeit significant, risk.

Why it matters for the IPO

The Musk lawsuit represents a direct threat to the legal and financial architecture of a potential OpenAI IPO [3]. A ruling that reverses the company's conversion to a PBC would invalidate its current capital structure, making a public offering impossible without another complete overhaul [2], [4]. This legal uncertainty emerges as OpenAI is reportedly laying the groundwork for a public listing as early as the fourth quarter of 2026, with a potential valuation approaching $1 trillion [1], [9].

The trial adds a major legal risk to an already complex pre-IPO narrative, which includes significant financial and competitive pressures:

  • High Cash Burn: The company remains deeply unprofitable, with internal projections showing losses of $14 billion and a cash burn of $17 billion in 2026 [1], [2]. Profitability is not expected until around 2030, a long time horizon for public market investors to underwrite [1], [4].
  • Execution Concerns: The Wall Street Journal reported in April 2026 that OpenAI had missed internal revenue and user targets, and that CFO Sarah Friar had privately suggested delaying an IPO until 2027, cautioning that the company was not yet ready for public-company reporting standards [2], [6].
  • Intense Competition: Rival Anthropic is also preparing for a late-2026 listing and has seen its annualized revenue and secondary-market valuation surge, creating a potential race to market that could impact investor appetite [1], [2]. Meanwhile, Google's Gemini has significantly eroded ChatGPT's share of AI web traffic over the past year [2].

What changes the market next

The path and timing for an OpenAI IPO now hinge on several key developments. The most immediate is the outcome of the Musk v. Altman trial, with an advisory verdict expected by mid-May 2026 [2]. A favorable ruling for OpenAI would remove a critical obstacle, whereas an adverse one could indefinitely postpone any public offering.

Beyond the courtroom, the next definitive catalyst would be the filing of an S-1 registration statement with the SEC, which would provide the first official, audited look at the company’s financials and confirm its intent to list [3]. Investors will also scrutinize the company's ability to sustain its rapid revenue growth—which reached a $25 billion annualized run rate in early 2026—and demonstrate progress in its enterprise segment, which is projected to reach parity with its consumer business by the end of the year [2], [8]. Finally, the timing of a potential IPO by rival Anthropic could force OpenAI to either accelerate its own plans or cede the first-mover advantage in defining the generative AI sector for public investors [2], [7].